Clinical Trial Update: Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating autologous mesenchymal stem cells combined with biomaterials to enhance bone healing in delayed unions after fractures of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Union of Fracture
• Fracture of Femur
• Fracture of Humerus
• Fracture of Tibia

Drugs mentioned

• Autologous Mesenchymal Stem Cells with Biomaterial Scaffold (Autologous mesenchymal stem cells with biomaterial scaffold)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Delayed Union After Fracture of Humerus, Tibial or Femur | Phase 2 | Status: COMPLETED